Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 10/20 | 0.57 |
| ▸ | NTSR2 | O95665 | 7/20 | 0.57 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30767678 | 0.89 | CALCR (0.57) | NTSR1NTSR2SORT1OPRM1OPRD1 | |
| SCHEMBL30767703 | 0.88 | CALCR (0.57) | NTSR1OPRM1OPRD1OPRK1 | |
| SCHEMBL31410865 | 0.88 | SLC6A2 (0.64) | NTSR1NTSR2SORT1SLC6A2OPRM1 | |
| SCHEMBL30767697 | 0.88 | CALCR (0.59) | NTSR1OPRM1OPRD1OPRK1 | |
| SCHEMBL31307249 | 0.87 | SLC6A2 (0.66) | NTSR1NTSR2SORT1SLC6A2OPRM1 | |
| SCHEMBL30767715 | 0.87 | CALCR (0.58) | NTSR1OPRM1OPRD1OPRK1 | |
| SCHEMBL30385288 | 0.87 | NTSR1 (0.60) | NTSR1NTSR2SORT1OPRM1OPRD1 | |
| SCHEMBL30242503 | 0.86 | SLC6A2 (0.63) | NTSR1NTSR2SORT1SLC6A2OPRM1 | |
| SCHEMBL31018327 | 0.85 | NTSR1 (0.56) | NTSR1NTSR2SORT1OPRM1OPRD1 | |
| SCHEMBL31410882 | 0.85 | SLC6A2 (0.67) | NTSR1NTSR2SORT1SLC6A2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
| US-20230293681-A1 | Antagonism of the VIP Signaling Pathway | EMORY UNIVERSITY | 2023-09-21 | — | — | US | disclosed |
| US-20230080520-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2023-03-16 | — | — | US | disclosed |
| US-11464855-B2 | Antagonism of the VIP signaling pathway | EMORY UNIVERSITY (US) | 2022-10-11 | — | — | US | disclosed |
| US-11278595-B2 | Peptides comprising non-natural amino acids and methods of making and using the same | LONGEVITY BIOTECH, INC. (US) | 2022-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230080520-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | APLNR, SCTR, GIPR | NTSR1 13/4885NTSR2 29/4885SORT1 1229/4885 |
| US-11278595-B2 | Peptides comprising non-natural amino acids and methods of making and using the same | APLNR, SCTR, GIPR | NTSR1 13/4885NTSR2 29/4885SORT1 1229/4885 |
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | NTSR1 18/4885NTSR2 42/4885SORT1 703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.